The Market Bureau of Fucheng County strengthened the prevention and control of epidemics in pharmaceutical companies. Law enforcement officers delivered notices on prevention and control measures during the epidemic period and signed an epidemic prevention and control commitment letter on the spot. Some pharmaceutical companies that did not receive the notification of control measures and signed the commitment letter in time were sent to Wechat group, the first time to urge companies to notify the printing and posting, and sign the letter of commitment to send the Wechat group and print it for retention. On July 30, 2021, 61 copies of the notice of control measures during the epidemic period and the signing of an epidemic prevention and control commitment letter were issued on the same day. On this basis, notices of prevention and control measures during the epidemic have been forwarded on WeChat groups for many times, and pharmaceutical companies are required to: insist on wearing masks on a daily basis, insist on implementing the “one meter line” distance requirement, insist on normalization of temperature test codes, and insist on eliminating and ventilating Regularization, adhere to the regularization of screening for feverish personnel, regularization of monitoring and early warning, give full play to the "sentinel" role of pharmacies, strengthen the registration and control of the four types of drug sales of "retire and double antibodies", and strictly implement the process of handling feverish personnel in accordance with abnormal situations.

Our bureau requires companies to post the registration ledgers of the personnel entering the store and the registration ledgers of the "four types of drugs" sales to the WeChat group after the business closes every day. In the future, two groups will be divided into two groups to conduct irregular inspections of drug operating companies in the jurisdiction. For those operating companies that are found to be inadequate during the epidemic period, they will be resolutely suspended for rectification, and in accordance with the "Pharmaceutical Management Law of the People's Republic of China" and "Pharmaceutical Business Quality Management Regulations" 》Initial investigation and punishment.